Nutex Health reported impressive financial results for Q1 2025, with a significant increase in total revenue and net income compared to Q1 2024.
The company restated its financial statements, resulting in adjustments to liabilities, equity, and net income.
Key metrics like revenue, EBITDA, and adjusted EBITDA showed substantial improvements year over year.
Revenue Growth
Total revenue for Q1 2025 was $211.8 million, a 214.0% increase from $67.5 million in Q1 2024.
Net Income Surge
Net income attributable to Nutex Health Inc. soared to $21.2 million in Q1 2025 from a net loss of $0.4 million in Q1 2024.
Operational Efficiency
EBITDA rose to $51.5 million in Q1 2025, a 624.7% increase from $7.1 million in Q1 2024.
Restatement Impact
The restatement led to adjustments in stock-based compensation, resulting in improved financial standing and metrics.
- The restated financial results showcase Nutex Health's robust performance and strategic financial management.
- Revenue growth, operational income, and net income improvements highlight the company's successful business strategy and execution.
Nutex Health's restated financial results reflect a period of significant growth and operational efficiency, demonstrating the company's resilience and commitment to value creation.